Get Involved Bringing Joy to the Pediatric Ward Students Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients. by Bradley Jones Get Involved Cakes for Cancer Inspired by a family friend, Chase Sloan has published a recipe book with proceeds going toward cancer research. by Erin O'Donnell Roadblocks to Care Some cancer patients struggle to find transportation to their appointments. The coronavirus pandemic has further limited options for patients looking for rides. by Anna Goshua Get Involved Smiling Faces Rich Nardiello seeks to bring a smile to children with cancer. by Bradley Jones Survivor Profile An Unlikely Pivot Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers. by Lindsey Konkel Get Involved Patients With Pets A helping hand for pet owners receiving cancer treatment. by Jackie Oshiro Virtual Connection in a Time of Social Distance Responding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones. by Marci A. Landsmann Get Involved Filling a Void A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers. by Elizabeth Rosto Sitko Survivor Profile A Driving Force Mark Good uses every avenue to spread the news about prostate cancer. by Lindsey Konkel Get Involved Creative Therapy Various kinds of artistic expression can play a role in processing the emotional effects of cancer. by Bradley Jones next Cancer Talk Drug Delays Recurrence in People With Early-Stage Breast Cancer People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor. by Pamela Rafalow Grossman Open Medical Records: Pros and Cons Patients now have full access to their online medical records. What are the benefits and downsides? by Jen Tota McGivney Remote Care After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment. by Jon Kelvey Moving Away From the Maximum Tolerated Dose The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate. by Marcus A. Banks More Posts